Izumi Kawachi
Niigata, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Clinical Characterization and Long-Term Outcome in Children and Adults With Anti-AMPA Receptor Encephalitis.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 18, 2025
Development of Severity Classification Criteria for Acute Neuro-Behçet's Disease.
Journal: Internal medicine (Tokyo, Japan)
Published: June 11, 2025
Multiancestry genome-wide association and multiomics analyses elucidate spatiocellular features of multiple sclerosis genetics.
Journal: Nature genetics
Published: May 07, 2025
Safety and Effectiveness of Satralizumab in Japanese Patients with Neuromyelitis Optica Spectrum Disorder: A 30‑Month Interim Analysis of Post‑marketing Surveillance.
Journal: Neurology and therapy
Published: April 18, 2025
Long-Term Clinical Landscapes of Spinal Hypertrophic Pachymeningitis With Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis.
Journal: Neurology
Published: March 19, 2025
Reconsideration of conversion to multiple sclerosis: one-year cerebral lesion appearance rate of Japanese aquaporin-4 antibody-negative optic neuritis patients.
Journal: Japanese journal of ophthalmology
Published: March 13, 2025
Clinical profile of IgG4-related disease in Japan based on the rare disease data registry.
Journal: Immunological medicine
Published: November 28, 2024
Prevalence of, and Disability Due to, Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder in Japan by the Fifth Nationwide Survey.
Journal: Neurology
Published: October 30, 2024
Effectiveness of satralizumab in a real-world clinical setting in Japan: Interleukin-6 receptor inhibition in neuromyelitis optica spectrum disorder: A six-month interim analysis of a multicenter medical chart review.
Journal: Multiple sclerosis and related disorders
Published: July 31, 2024
Contribution of germline and somatic mutations to risk of neuromyelitis optica spectrum disorder.
Journal: Cell genomics
Published: May 20, 2024
A multicenter, retrospective study in patients with multiple sclerosis treated with natalizumab in a real-world setting in Japan: The REFIND study.
Journal: Multiple sclerosis and related disorders
Published: March 19, 2024
Stage-dependent immunity orchestrates AQP4 antibody-guided NMOSD pathology: a role for netting neutrophils with resident memory T cells in situ.
Journal: Acta neuropathologica
Published: February 13, 2024
Last Updated: 09/26/2026